Avidity Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 05/12/2025 | 15.62 M | $460.96 M | -5.42% | 12.08% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 11.43 M | $361.13 M | 62.01% | 8.84% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 11.34 M | $334.70 M | 2.67% | 8.77% |
BLACKROCK, INC. | 05/02/2025 | 9.92 M | $292.76 M | -0.15% | 7.67% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 9.68 M | $285.89 M | 19.47% | 7.49% |
VANGUARD GROUP INC | 05/09/2025 | 9.24 M | $272.86 M | -2.00% | 7.15% |
RTW INVESTMENTS, LP | 05/15/2025 | 8.75 M | $258.21 M | 10.26% | 6.77% |
AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 7.63 M | $225.09 M | 1.67% | 5.90% |
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 6.30 M | $185.99 M | 0.00% | 4.88% |
STATE STREET CORP | 05/15/2025 | 4.32 M | $127.57 M | -6.10% | 3.34% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.76 M | $81.35 M | -1.86% | 2.13% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 2.15 M | $63.35 M | -22.02% | 1.66% |
CASDIN CAPITAL, LLC | 05/15/2025 | 2.05 M | $60.37 M | 0.00% | 1.58% |
ORBIMED ADVISORS LLC | 05/15/2025 | 1.81 M | $53.52 M | 62.90% | 1.40% |
POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 1.79 M | $52.81 M | 40.65% | 1.38% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.57 M | $46.48 M | 781.63% | 1.22% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.27 M | $37.52 M | 3.49% | 0.98% |
SIREN, L.L.C. | 05/23/2025 | 1.11 M | $32.79 M | -1.48% | 0.86% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.02 M | $30.22 M | -0.52% | 0.79% |
NORTHERN TRUST CORP | 05/13/2025 | 1.02 M | $30.07 M | -5.65% | 0.79% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/14/2025 | 928.23 K | $27.40 M | -8.57% | 0.72% |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 873.22 K | $25.78 M | 9.29% | 0.68% |
WOODLINE PARTNERS LP | 05/15/2025 | 865.93 K | $25.56 M | 0.01% | 0.67% |
05/15/2025 | 865.00 K | $25.53 B | -49.92% | 0.67% | |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 784.70 K | $23.16 M | 2.84% | 0.61% |
FIERA CAPITAL CORP | 05/07/2025 | 772.30 K | $22.80 M | 92.51% | 0.60% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 771.16 K | $22.77 M | 100.00% | 0.60% |
BIOIMPACT CAPITAL LLC | 05/15/2025 | 714.22 K | $21.08 M | 1.60% | 0.55% |
ECOR1 CAPITAL, LLC | 05/15/2025 | 557.58 K | $16.46 B | 0.00% | 0.43% |
MORGAN STANLEY | 05/15/2025 | 525.70 K | $15.52 M | -56.69% | 0.41% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 525.00 K | $15.50 M | 100.00% | 0.41% |
MARSHALL WACE, LLP | 05/15/2025 | 455.20 K | $13.44 M | 179.50% | 0.35% |
JPMORGAN CHASE & CO | 05/12/2025 | 440.80 K | $13.01 M | -2.08% | 0.34% |
CANDRIAM S.C.A. | 05/14/2025 | 439.10 K | $12.96 M | 21.73% | 0.34% |
TD ASSET MANAGEMENT INC | 05/07/2025 | 433.14 K | $12.79 M | 4.33% | 0.34% |
05/12/2025 | 431.21 K | $12.73 M | 100.00% | 0.33% | |
ALETHEA CAPITAL MANAGEMENT, LLC | 05/14/2025 | 421.72 K | $12.45 M | 0.20% | 0.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 411.31 K | $12.14 M | -24.34% | 0.32% |
CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 400.00 K | $11.81 M | -61.90% | 0.31% |
FINEPOINT CAPITAL LP | 05/14/2025 | 380.70 K | $11.24 M | -2.71% | 0.29% |
SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 379.93 K | $11.22 M | 2,655.32% | 0.29% |
CITIGROUP INC | 05/12/2025 | 377.28 K | $11.14 M | 98.62% | 0.29% |
EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2025 | 375.92 K | $11.10 M | 0.00% | 0.29% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 366.59 K | $10.82 M | 0.99% | 0.28% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 357.72 K | $10.56 M | 7.62% | 0.28% |
LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 350.00 K | $10.33 B | 100.00% | 0.27% |
VOYA INVESTMENT MANAGEMENT LLC | 05/15/2025 | 332.18 K | $9.81 M | -4.05% | 0.26% |
ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 329.98 K | $9.74 M | 1,080.60% | 0.26% |
BARCLAYS PLC | 05/15/2025 | 323.90 K | $9.56 M | 29.55% | 0.25% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 300.00 K | $8.86 M | -25.00% | 0.23% |
Avidity Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 277 institutional investors and hedge funds held shares of Avidity Biosciences, Inc.. The most heavily invested institutionals were:
FMR LLC: 15.62 M
JANUS HENDERSON GROUP PLC: 11.43 M
PRICE T ROWE ASSOCIATES INC /MD/: 11.34 M
BlackRock, Inc.: 9.92 M
WELLINGTON MANAGEMENT GROUP LLP: 9.68 M
VANGUARD GROUP INC: 9.24 M
103.21% of Avidity Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 143.43 M shares in the last 24 months. This purchase volume represents approximately $4.40 B in transactions.